[go: up one dir, main page]

PE20070362A1 - COMPOUNDS DERIVED FROM INDAZOLE-4-IL-2,4-PYRIMIDINDIAMINE AS INHIBITORS OF TYROSINE KINASE (KINASE Syk) - Google Patents

COMPOUNDS DERIVED FROM INDAZOLE-4-IL-2,4-PYRIMIDINDIAMINE AS INHIBITORS OF TYROSINE KINASE (KINASE Syk)

Info

Publication number
PE20070362A1
PE20070362A1 PE2006000835A PE2006000835A PE20070362A1 PE 20070362 A1 PE20070362 A1 PE 20070362A1 PE 2006000835 A PE2006000835 A PE 2006000835A PE 2006000835 A PE2006000835 A PE 2006000835A PE 20070362 A1 PE20070362 A1 PE 20070362A1
Authority
PE
Peru
Prior art keywords
pyrimidindiamine
kinase
inhibitors
bencisotiazol
dihidro
Prior art date
Application number
PE2006000835A
Other languages
Spanish (es)
Inventor
Sebastien Andre Campos
Lee Andrew Harrison
Vipulkumar Kantibhai Patel
Giovanni Vitulli
Nigel James Parr
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0514580A external-priority patent/GB0514580D0/en
Priority claimed from GB0524785A external-priority patent/GB0524785D0/en
Priority claimed from GB0601728A external-priority patent/GB0601728D0/en
Priority claimed from GB0606763A external-priority patent/GB0606763D0/en
Priority claimed from GB0610513A external-priority patent/GB0610513D0/en
Priority claimed from GB0610924A external-priority patent/GB0610924D0/en
Priority claimed from GB0611488A external-priority patent/GB0611488D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20070362A1 publication Critical patent/PE20070362A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE R1 Y R2 SON CADA UNO H, ALQUILO(C1-C6) O CH2-CICLOALQUILO(C3-C7); R3 ES ALQUILO(C1-C3) O ALQUILO(C2-C3) SUSTITUIDO CON OH O ALCOXI(C1-C3); X ES HALOGENO. SON COMPUESTOS PREFERIDOS: N2-(1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL)-N4-ETIL-5-FLUORO-N4-1H-INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA, 5-CLORO-N2-(1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL)-N4-ETIL-N4-1H-INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA, 5-BROMO-N2-(1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL)-N4-ETIL-N4-1H-INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA TIROSINA QUINASA (QUINASA Syk) SIENDO UTILES EN EL TRATAMIENTO DE TRASTORNOS INFLAMATORIOS Y ALERGICOS TALES COMO ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, ASMA, COLITIS ULCEROSA, ENFERMEDAD DE CROHNREFERS TO COMPOUNDS OF FORMULA (I) WHERE R1 AND R2 ARE EACH H, ALKYL (C1-C6) OR CH2-CYCLOALKYL (C3-C7); R3 IS ALKYL (C1-C3) OR ALKYL (C2-C3) SUBSTITUTED WITH OH OR ALCOXY (C1-C3); X IS HALOGEN. THE PREFERRED COMPOUNDS ARE: N2- (1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL) -N4-ETIL-5-FLUORO-N4-1H-INDAZOL-4-IL-2, 4-PYRIMIDINDIAMINE, 5-CHLORO-N2- (1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL) -N4-ETIL-N4-1H-INDAZOL-4-IL-2, 4-PYRIMIDINDIAMINE, 5-BROMO-N2- (1,1-DIOXIDO-2,3-DIHIDRO-1,2-BENCISOTIAZOL-6-IL) -N4-ETIL-N4-1H-INDAZOL-4-IL-2, 4-PYRIMIDINDIAMINE, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION AND A PREPARATION PROCEDURE. THESE COMPOUNDS ARE INHIBITORS OF TYROSINE KINASE (KINASE Syk), BEING USEFUL IN THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS SUCH AS CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, ULCEROUS COLIHNTIS, CROSS DISEASE

PE2006000835A 2005-07-15 2006-07-13 COMPOUNDS DERIVED FROM INDAZOLE-4-IL-2,4-PYRIMIDINDIAMINE AS INHIBITORS OF TYROSINE KINASE (KINASE Syk) PE20070362A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0514580A GB0514580D0 (en) 2005-07-15 2005-07-15 Novel compounds
GB0524785A GB0524785D0 (en) 2005-12-05 2005-12-05 Novel compounds
GB0601728A GB0601728D0 (en) 2006-01-27 2006-01-27 Novel Compounds
GB0606763A GB0606763D0 (en) 2006-04-03 2006-04-03 Novel compounds
GB0610513A GB0610513D0 (en) 2006-05-26 2006-05-26 Novel compounds
GB0610924A GB0610924D0 (en) 2006-06-02 2006-06-02 Novel compounds
GB0611488A GB0611488D0 (en) 2006-06-09 2006-06-09 Novel compounds

Publications (1)

Publication Number Publication Date
PE20070362A1 true PE20070362A1 (en) 2007-04-23

Family

ID=37022880

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000835A PE20070362A1 (en) 2005-07-15 2006-07-13 COMPOUNDS DERIVED FROM INDAZOLE-4-IL-2,4-PYRIMIDINDIAMINE AS INHIBITORS OF TYROSINE KINASE (KINASE Syk)

Country Status (4)

Country Link
AR (1) AR054834A1 (en)
PE (1) PE20070362A1 (en)
TW (1) TW200740805A (en)
WO (1) WO2007009681A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085540A1 (en) * 2006-01-27 2007-08-02 Glaxo Group Limited 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
KR20100042272A (en) 2007-07-16 2010-04-23 아스트라제네카 아베 Pyrimidine derivatives 934
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
AU2012253886A1 (en) 2011-05-10 2013-10-31 Merck Sharp & Dohme Corp. Pyridyl aminopyridines as Syk inhibitors
JP2014513686A (en) 2011-05-10 2014-06-05 メルク・シャープ・アンド・ドーム・コーポレーション Aminopyrimidines as Syk inhibitors
EP2706852B1 (en) 2011-05-10 2018-08-22 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as syk inhibitors
US8987456B2 (en) 2011-10-05 2015-03-24 Merck Sharp & Dohme Corp. 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
US9216173B2 (en) 2011-10-05 2015-12-22 Merck Sharp & Dohme Corp. 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
US9006444B2 (en) 2011-10-05 2015-04-14 Merck Sharp & Dohme Corp. Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
EP2863914B1 (en) 2012-06-20 2018-10-03 Merck Sharp & Dohme Corp. Pyrazolyl derivatives as syk inhibitors
EP2863913B1 (en) 2012-06-20 2018-09-12 Merck Sharp & Dohme Corp. Imidazolyl analogs as syk inhibitors
US9376418B2 (en) 2012-06-22 2016-06-28 Merck Sharp & Dohme Corp. Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
US9416111B2 (en) 2012-06-22 2016-08-16 Merck Sharp & Dohme Corp. Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
US9353066B2 (en) 2012-08-20 2016-05-31 Merck Sharp & Dohme Corp. Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
WO2014048065A1 (en) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Triazolyl derivatives as syk inhibitors
CN103864764A (en) * 2012-12-11 2014-06-18 齐鲁制药有限公司 Indazole-substituted pyrimidinamine derivative, and preparation method and use thereof
EP2931281B1 (en) 2012-12-12 2018-01-17 Merck Sharp & Dohme Corp. Amino-pyrimidine-containing spleen tyrosine kinase inhibitors
WO2014100314A1 (en) 2012-12-21 2014-06-26 Merck Sharp & Dohme Corp. Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
US9745295B2 (en) 2013-04-26 2017-08-29 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
EP2988749B1 (en) 2013-04-26 2019-08-14 Merck Sharp & Dohme Corp. Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
US9822107B2 (en) 2013-12-20 2017-11-21 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
EP3082807B1 (en) 2013-12-20 2018-07-04 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
US9670196B2 (en) 2013-12-20 2017-06-06 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
WO2015138273A1 (en) 2014-03-13 2015-09-17 Merck Sharp & Dohme Corp. 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
CA3129665A1 (en) 2019-03-21 2020-09-24 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
JP2023500906A (en) 2019-11-08 2023-01-11 インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） Methods of treating cancers with acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031073A1 (en) * 1997-12-15 1999-06-24 Yamanouchi Pharmaceutical Co., Ltd. Novel pyrimidine-5-carboxamide derivatives
MXPA02007957A (en) * 2000-02-17 2002-11-29 Amgen Inc Kinase inhibitors.
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
DE60330466D1 (en) * 2002-07-29 2010-01-21 Rigel Pharmaceuticals Inc METHOD FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINE-IAMINE COMPOUNDS
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
BRPI0413616B8 (en) * 2003-08-15 2021-05-25 Irm Llc 2,4-pyrimidinediamines, their uses, and pharmaceutical composition

Also Published As

Publication number Publication date
TW200740805A (en) 2007-11-01
WO2007009681A1 (en) 2007-01-25
AR054834A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
PE20070362A1 (en) COMPOUNDS DERIVED FROM INDAZOLE-4-IL-2,4-PYRIMIDINDIAMINE AS INHIBITORS OF TYROSINE KINASE (KINASE Syk)
PE20090288A1 (en) QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS
DOP2006000210A (en) AMIDA PYRIMIDINE COMPOUNDS AS PGDS INHIBITORS
MY154895A (en) Pyrimidine hydrazide compounds as pgds inhibitors
PE20160869A1 (en) NOVEL DERIVATIVES OF AMINO PYRIMIDINE
NO20084418L (en) Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
CY1122500T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUTARIMIDE DERIVATIVES, AND ITS USE FOR THE TREATMENT OF EOSINOPHILIC DISEASES
PE20220934A1 (en) AMINOQUINAZOLINE DERIVATIVES AS P2X PURINORECEPTOR 3 (P2X3) INHIBITORS
CL2012001221A1 (en) Compounds derived from 4 - (1h-pyrrol-1-yl) pyrimidin -2-ylamino and 4 - (1h-pyrazol-1-yl) -pyrimidin-2-ylamino, kinase inhibitors; an isomeric compound; pharmaceutical composition; Useful in the treatment of asthma, chronic obstructive pulmonary disease, ulcerative colitis, Crohn's disease, bronchitis, dermatitis, among others.
PE20120321A1 (en) INDAZOLES SUBSTITUTED WITH OXAZOLE AS PI3-KINASE INHIBITORS
PH12012501122A1 (en) Pteridinones as inhibitors of polo-like kinase
PE20141404A1 (en) DERIVATIVES OF HAVE [3,2-D] PYRIMIDINE WHICH HAVE INHIBITING ACTIVITY BY KINASES OF PROTEINS
MA35285B1 (en) indazoles
NO20090723L (en) Condensed heterocyclic derivatives and methods of use
NO20076502L (en) Pyrrolopyridines useful as inhibitors of protein kinase
PE20131464A1 (en) QUINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS PI3 KINASE INHIBITORS
PE20121352A1 (en) HETEROARYL DERIVATIVES CONTAINING N AS INHIBITORS OF KINASE JAK3
NO20083514L (en) Heterobicyclic sulfonamide derivatives for the treatment of diabetes
EA201190158A1 (en) Derivatives of benzofuranyl for use as glucose kinase inhibitors
ATE538100T1 (en) AMINOTETRAHYDROINDAZOLOACETIC ACIDS
NO20070445L (en) Pyrimidine.
EA200801996A1 (en) 2-SUBSTITUTED DERIVATIVES OF 4-BENZIL-PHTHALASINONES AS HISTAMINE H1-AND H3-ANTAGONISTS
PE20091035A1 (en) DERIVATIVES OF 2-AMINOPYRIMIDINE
MX2011013884A (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof.
AR078552A1 (en) PHENYLOXADIAZOL DERIVATIVES AS INHIBITING AGENTS OF THE PGDS

Legal Events

Date Code Title Description
FC Refusal